罕见呼吸系统疾病迎来黄金时代：从罕见病日到欧洲参考网络。 - Suppr

Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.

作者信息

Humbert Marc, Wagner Thomas O

机构信息

Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, Le Kremlin Bicêtre, France

Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre (Assistance Publique Hôpitaux de Paris), Le Kremlin-Bicêtre, France.

出版信息

Eur Respir J. 2017 Feb 23;49(2). doi: 10.1183/13993003.00085-2017. Print 2017 Feb.

DOI:10.1183/13993003.00085-2017

PMID:28232421

Abstract

摘要

相似文献

Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.

Eur Respir J. 2017 Feb 23;49(2). doi: 10.1183/13993003.00085-2017. Print 2017 Feb.

"Education is the passport to the future": enabling today's medical teachers to prepare tomorrow's respiratory health practitioners.

Eur Respir J. 2014 Sep;44(3):578-84. doi: 10.1183/09031936.00109314.

National registries of rare diseases in Europe: an overview of the current situation and experiences.

Public Health Genomics. 2015;18(1):20-5. doi: 10.1159/000365897. Epub 2014 Sep 9.

An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health.

Eur Respir J. 2013 Oct;42(4):906-15. doi: 10.1183/09031936.00062113.

Implementing the European Respiratory Roadmap: halfway there?

Eur Respir J. 2014 Nov;44(5):1127-9. doi: 10.1183/09031936.00152814.

[Rare diseases in pulmonary medicine and its challenges].

Pneumologie. 2012 Jul;66(7):437-41. doi: 10.1055/s-0032-1309876. Epub 2012 Jun 12.

The European Union Policy in the Field of Rare Diseases.

Adv Exp Med Biol. 2017;1031:561-587. doi: 10.1007/978-3-319-67144-4_30.

[European Reference Networks : Consequences for healthcare in Germany].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):537-541. doi: 10.1007/s00103-017-2533-x.

The importance of international collaboration for rare diseases research: a European perspective.

Gene Ther. 2017 Sep;24(9):562-571. doi: 10.1038/gt.2017.29. Epub 2017 Jul 27.

The countdown for rare disease strategies is underway.

Lancet Neurol. 2013 Jan;12(1):1. doi: 10.1016/S1474-4422(12)70312-5.

引用本文的文献

Priorities and barriers for research related to primary ciliary dyskinesia.

ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00026-2024. eCollection 2024 Sep.

The flare of care for rare: per aspera ad astra for rare lung diseases!

Eur Respir Rev. 2023 Feb 7;32(167). doi: 10.1183/16000617.0006-2023. Print 2023 Mar 31.

Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue.

J Clin Med. 2021 Dec 16;10(24):5906. doi: 10.3390/jcm10245906.

Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs.

Eur Respir Rev. 2021 Dec 22;30(162). doi: 10.1183/16000617.0258-2021. Print 2021 Dec 31.

Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what's down the road?

Ther Adv Chronic Dis. 2021 Jul 29;12_suppl:20406223211014025. doi: 10.1177/20406223211014025. eCollection 2021.

Educational aspects of rare and orphan lung diseases.

Respir Res. 2021 Mar 24;22(1):92. doi: 10.1186/s12931-021-01676-1.

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.

Int J Chron Obstruct Pulmon Dis. 2020 Feb 12;15:345-355. doi: 10.2147/COPD.S234646. eCollection 2020.

Pulmonary arterial hypertension registries: past, present and into the future.

Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.

Rare pulmonary disease and orphan drugs: a path to the future.

Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0115-2019. Print 2019 Sep 30.

Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1.

BMC Proc. 2018 Mar 5;12(Suppl 2):1. doi: 10.1186/s12919-018-0098-9. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.

Eur Respir J. 2017 Feb 23;49(2). doi: 10.1183/13993003.00085-2017. Print 2017 Feb.

"Education is the passport to the future": enabling today's medical teachers to prepare tomorrow's respiratory health practitioners.

Eur Respir J. 2014 Sep;44(3):578-84. doi: 10.1183/09031936.00109314.

National registries of rare diseases in Europe: an overview of the current situation and experiences.

Public Health Genomics. 2015;18(1):20-5. doi: 10.1159/000365897. Epub 2014 Sep 9.

An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health.

Eur Respir J. 2013 Oct;42(4):906-15. doi: 10.1183/09031936.00062113.

Implementing the European Respiratory Roadmap: halfway there?

Eur Respir J. 2014 Nov;44(5):1127-9. doi: 10.1183/09031936.00152814.

[Rare diseases in pulmonary medicine and its challenges].

Pneumologie. 2012 Jul;66(7):437-41. doi: 10.1055/s-0032-1309876. Epub 2012 Jun 12.

The European Union Policy in the Field of Rare Diseases.

Adv Exp Med Biol. 2017;1031:561-587. doi: 10.1007/978-3-319-67144-4_30.

[European Reference Networks : Consequences for healthcare in Germany].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):537-541. doi: 10.1007/s00103-017-2533-x.

The importance of international collaboration for rare diseases research: a European perspective.

Gene Ther. 2017 Sep;24(9):562-571. doi: 10.1038/gt.2017.29. Epub 2017 Jul 27.

The countdown for rare disease strategies is underway.

Lancet Neurol. 2013 Jan;12(1):1. doi: 10.1016/S1474-4422(12)70312-5.

引用本文的文献

Priorities and barriers for research related to primary ciliary dyskinesia.

ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00026-2024. eCollection 2024 Sep.

The flare of care for rare: per aspera ad astra for rare lung diseases!

Eur Respir Rev. 2023 Feb 7;32(167). doi: 10.1183/16000617.0006-2023. Print 2023 Mar 31.

Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue.

J Clin Med. 2021 Dec 16;10(24):5906. doi: 10.3390/jcm10245906.

Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs.

Eur Respir Rev. 2021 Dec 22;30(162). doi: 10.1183/16000617.0258-2021. Print 2021 Dec 31.

Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what's down the road?

Ther Adv Chronic Dis. 2021 Jul 29;12_suppl:20406223211014025. doi: 10.1177/20406223211014025. eCollection 2021.

Educational aspects of rare and orphan lung diseases.

Respir Res. 2021 Mar 24;22(1):92. doi: 10.1186/s12931-021-01676-1.

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.

Int J Chron Obstruct Pulmon Dis. 2020 Feb 12;15:345-355. doi: 10.2147/COPD.S234646. eCollection 2020.

Pulmonary arterial hypertension registries: past, present and into the future.

Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.

Rare pulmonary disease and orphan drugs: a path to the future.

Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0115-2019. Print 2019 Sep 30.

Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1.

BMC Proc. 2018 Mar 5;12(Suppl 2):1. doi: 10.1186/s12919-018-0098-9. eCollection 2018.

Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献